The discovery of insulin in 1921 changed the prognosis for people with type 1 diabetes. A
century later, availability and affordability of insulin remain a challenge in many parts of the …

Substantial attention has been given to the issue of access to medicines for communicable
diseases; however, access to essential medicines for diabetes, especially insulin, has had …

OBJECTIVE We examined changes in glucose-lowering medication spending and
quantified the magnitude of factors that are contributing to these changes. RESEARCH …

Introduction High prices for insulin pose a barrier to treatment for people living with diabetes,
with an estimated 50% of 100 million patients needing insulin lacking reliable access. As …

Background Insulin is the primary treatment for type 1 and some type 2 diabetes but remains
costly in the United States, even though it was discovered more than a century ago. High …

Insulin was discovered in 1921 and soon became widely available in high-income countries.
However, many people currently in need of this life-saving medicine are unable to access it …

Importance The burden of diabetes is growing worldwide. The costs associated with
diabetes put substantial pressure on patients and health budgets, especially in low-and …

Executive summary The year 2021 marks 100 years since the momentous discovery of
insulin in 1921, which marked a turning point in care for those with diabetes mellitus …

Background Not all new drug products are truly new. Some are the result of marginal
innovation and incremental patenting of existing products, but in such a way that confers no …

Background Poor access to affordable insulin results in serious and needless complications
and premature deaths for those with diabetes who need this essential medicine. To help …